Sign in Subscribe
Coronaviruses

COVID-19 Research Uncovers Distinct Inflammatory Pathways and BMI Association

Strategic Insights

— 1 min read

Research from Johns Hopkins University has provided fresh insights into the mechanisms underlying severe COVID-19. The study, published in the journal Clinical Infectious Diseases, compared cytokines and chemokines in patients with COVID-19 and influenza, identifying distinct inflammatory pathways and a cytokine mediator of the effect of BMI. The findings highlight key differences in pathobiology between severe acute respiratory syndrome coronavirus 2 (Sars-cov-2) and influenza infection.

Key Takeaways:

  • The study found that severe COVID-19 is marked by dysregulated inflammation and is associated with elevated BMI.
  • Cytokines such as interleukin-18 (IL-18), IL-1 beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha) were significantly increased in COVID-19 patients compared to influenza patients.
  • Random forest analysis identified high IL-6 and low IFN-lambda 1 levels as the most distinct between severe COVID-19 and severe influenza.
  • IL-1RA was identified as a potential mediator of the effects of BMI on COVID-19 severity.
  • The research was funded by multiple organizations, including Johns Hopkins COVID-19 Research Response Program, Johns Hopkins University Provost Research Grant, Bill & Melinda Gates Foundation, NIH National Cancer Institute (NCI), and others.
  • The study's lead author is Andrea L. Cox, from Johns Hopkins University's Department of Medicine.
  • Additional authors include Andrew H. Karaba, Leon L. Hsieh, Alexis Figueroa, and other researchers from Johns Hopkins University and other institutions.

Statistics:

  • 37 cytokines and chemokines were measured in plasma from 135 patients with COVID-19, 57 patients with influenza, and 30 healthy controls.
  • Cytokine levels were compared using linear regression and random forest analysis.
  • The study identified 13 cytokines significantly elevated in COVID-19 patients compared to influenza patients.
  • IL-6 levels were found to be significantly higher in severe COVID-19 patients compared to severe influenza patients.
  • The study's results have important implications for the development of mechanistic and therapeutic investigations for severe COVID-19.

Sources:

  • Clinical Infectious Diseases, 2022;74(2):254-262.
  • NewsRx. Study Findings on COVID-19 Are Outlined in Reports from Johns Hopkins University [Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) and Influenza Infection Highlight Key Differences In Pathobiology]. Respiratory Therapeutics Week. April 18, 2022; p 800.

Read more